1. Home
  2. STXS vs CBAN Comparison

STXS vs CBAN Comparison

Compare STXS & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • CBAN
  • Stock Information
  • Founded
  • STXS 1990
  • CBAN 1975
  • Country
  • STXS United States
  • CBAN United States
  • Employees
  • STXS N/A
  • CBAN N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CBAN Major Banks
  • Sector
  • STXS Health Care
  • CBAN Finance
  • Exchange
  • STXS Nasdaq
  • CBAN Nasdaq
  • Market Cap
  • STXS 275.9M
  • CBAN 300.7M
  • IPO Year
  • STXS 2004
  • CBAN 1998
  • Fundamental
  • Price
  • STXS $2.91
  • CBAN $15.99
  • Analyst Decision
  • STXS
  • CBAN
  • Analyst Count
  • STXS 0
  • CBAN 0
  • Target Price
  • STXS N/A
  • CBAN N/A
  • AVG Volume (30 Days)
  • STXS 539.8K
  • CBAN 50.6K
  • Earning Date
  • STXS 11-11-2025
  • CBAN 10-22-2025
  • Dividend Yield
  • STXS N/A
  • CBAN 2.88%
  • EPS Growth
  • STXS N/A
  • CBAN 26.78
  • EPS
  • STXS N/A
  • CBAN 1.59
  • Revenue
  • STXS $31,806,000.00
  • CBAN $122,550,000.00
  • Revenue This Year
  • STXS $30.98
  • CBAN $21.97
  • Revenue Next Year
  • STXS $49.86
  • CBAN $27.53
  • P/E Ratio
  • STXS N/A
  • CBAN $10.06
  • Revenue Growth
  • STXS 33.94
  • CBAN 12.48
  • 52 Week Low
  • STXS $1.54
  • CBAN $13.99
  • 52 Week High
  • STXS $3.59
  • CBAN $18.49
  • Technical
  • Relative Strength Index (RSI)
  • STXS 43.91
  • CBAN 40.96
  • Support Level
  • STXS $2.95
  • CBAN $15.81
  • Resistance Level
  • STXS $3.15
  • CBAN $16.90
  • Average True Range (ATR)
  • STXS 0.13
  • CBAN 0.44
  • MACD
  • STXS -0.03
  • CBAN -0.04
  • Stochastic Oscillator
  • STXS 6.37
  • CBAN 13.33

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About CBAN Colony Bankcorp Inc.

Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.

Share on Social Networks: